Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
End price
08.09.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Atara Biotherapeutics Inc. is performing very badly with a performance of -74.00%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atara Biotherapeutics Inc. | - | - | - |
| iShares Core DAX® | 0,02 % | 0,58 % | 11,67 % |
| iShares Nasdaq 100 | 1,74 % | -2,06 % | 4,18 % |
| iShares Nikkei 225® | 0,43 % | 10,49 % | 29,99 % |
| iShares S&P 500 | 1,33 % | 0,14 % | 3,33 % |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year